Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: September

Staff  |  Issue: September 2013  |  September 1, 2013

Coding Corner


A 68-year-old female patient with senile osteoporosis and rheumatoid arthritis returns to the office for her first Reclast infusion. The physician reviews the patient’s past lab results. The patient reports she still has pain, stiffness, and swelling in her left elbow, wrists, and lower back. Her pain is at a level of 8 out of 10 for severity. She denies any fevers, cough, or dyspnea. She currently is on a nonsteroidal antiinflammatory drug, weekly methotrexate injections, and folic acid. The physician performs an expanded problem-focused exam. The physician decides to add celecoxib to address the pain in her joints. Her past medical information reveals that last year she had a fracture of her left wrist from falling in her kitchen. The patient then receives IV Reclast 5-mg infusion over 20 minutes.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

How should this be coded? click here for the answer.

Share: 

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCodingInfusionReclast

Related Articles

    Coding Corner Answer: September Coding Challenge

    September 1, 2013

    Coding for a patient who receives a separate evaluation and management service on the same day as a Reclast infusion

    Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

    August 16, 2019

    Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Managing an In-Office Infusion Practice

    August 8, 2012

    The increased utilization of infusible biologics for the treatment of rheumatic diseases has opened the door for you to provide more integrated care for your patients. Having an in-office infusion center gives you the ability to deliver this service to your patients in a familiar and supportive setting.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences